Sarepta Therapeutics Inc.

NASDAQ: SRPT · Real-Time Price · USD
20.20
-0.79 (-3.76%)
At close: Aug 19, 2025, 3:59 PM
19.99
-1.02%
Pre-market: Aug 20, 2025, 07:25 AM EDT

Sarepta Therapeutics Revenue

Sarepta Therapeutics reported an annual revenue of $1.9B, reflecting a 52.97% growth. For the quarter ending June 30, 2025, Sarepta Therapeutics generated $611.09M in revenue.
Revenue (ttm)
1.9B
Revenue Growth
52.97%
Price / Sales Ratio
6.08
Revenue / Employee
1.39M
Employees
1,372
Market Cap
1.97B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 1.9B +52.97%
Dec 31, 2023 1.24B +33.26%
Dec 31, 2022 933.01M +32.93%
Dec 31, 2021 701.89M +29.96%
Dec 31, 2020 540.1M +41.82%
Dec 31, 2019 380.83M +26.51%
Dec 31, 2018 301.03M +94.74%
Dec 31, 2017 154.58M +2751.58%
Dec 31, 2016 5.42M +332.64%
Dec 31, 2015 1.25M -87.16%
Dec 31, 2014 9.76M -31.38%
Dec 31, 2013 14.22M -61.91%
Dec 31, 2012 37.33M -20.56%
Dec 31, 2011 46.99M +59.72%
Dec 31, 2010 29.42M +67.30%
Dec 31, 2009 17.59M -17.28%
Dec 31, 2008 21.26M +93.52%
Dec 31, 2007 10.99M +9428.23%
Dec 31, 2006 115.29K -97.59%
Dec 31, 2005 4.78M +1011.31%
Dec 31, 2004 430.46K -55.62%
Dec 31, 2003 969.87K +15.90%
Dec 31, 2002 836.78K +18.51%
Dec 31, 2001 706.1K -45.57%
Dec 31, 2000 1.3M +1197.34%
Dec 31, 1999 100K -50.00%
Dec 31, 1998 200K +100.00%
Dec 31, 1997 100K n/a
Dec 31, 1996 100K n/a
Dec 31, 1995 100K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.